Pelvic Health

DotLab Begins Enrollment in a Multi-Center Cohort Study for Its Non-Invasive Test for Endometriosis

DotLab, a healthcare technology company at the forefront of research and development to combat women’s health conditions, today announced the initiation of EMPOWER, a multi-center cohort study for endometriosis. The EMPOWER Study is designed to support future development activities for DotLab’s non-invasive test to aid in the diagnosis of active endometriosis. Last year, DotLab announced the publication of data in the American Journal…

The FDA Accepts UVision360’s Submission for the Novel LUMINELLE DTx System Biopsy Sheath

UVision360 announced earlier today that the U.S. Food and Drug Administration (FDA) has accepted the Company’s submission to expand the LUMINELLE DTx System portfolio to now include the LUMINELLE 360° Bx (Biopsy) Sheath. The LUMINELLE DTx System, is a compact hysteroscopy and cystoscopy system, designed to meet the needs of patients and physicians in the office setting. The novel and patented LUMINELLE…

Canada-based Utiva Launches a New Line of Urinary Tract Health and Wellness Products

Canada-based Utiva, whose vision is to provide best-in-class solutions to start a UTI-free life has recently annoucned the launch of its flagship line of urinary tract health and wellness supplements. The line comprises three point-of-need products: Utiva UTI Control 36PAC Cranberry Pills, D-Mannose Attack, and Probiotic Power Supplements, to serve as an effective wellness trio that can be customized and catered to your long…

Atlantic Therapeutics Attracts Two New Investors to Accelerate the Commercialization of INNOVO, Its Innovative Urinary Incontinence Treatment Technology

Atlantic Therapeutics, the Ireland-based company pioneering a non-invasive, wearable treatment for urinary incontinence, today announced it has raised significant new investment from the Dutch Borski Fund and the Western Development Commission in Ireland. The Borski Fund addresses the venture capital gender gap through investments in female-led and femtech companies, and their support for Atlantic Therapeutics is a strong endorsement of the progress…

Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health

Ferring Pharmaceuticals, Rebiotix, a Ferring Company, and MyBiotics Pharma today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age linked to increased risk of miscarriage and complications for pregnancy and fertility. The collaboration is an important step forward in harnessing the power of the human microbiome in this area…

Spain-based Endometrial Cancer Diagnostics Company MiMark Receives €1.5M Investment from EIT Health

Barcelona-based company MiMARK has received €1.5M in funding from EIT Health following the EIT Health Wild Card program. The company is working on improving accuracy and efficiency of diagnostics for endometrial cancer. Abnormal vaginal bleeding affects 9M women in EU and US yearly. Diagnosis of endometrial cancer is mandatory since 10% of these women will suffer it. Current diagnosis is based on the pathological…

Women’s Health Biotech Company Aspira Plans to Raise $45M with Its Recently Announced Public Offering of Common Stock

Aspira, a bio-analytical based women’s health company focused on gynecologic disease, has announced plans to raise $45 million through a public offering of common stock. The company intends to use the net proceeds from the offering for sales and marketing, working capital and other general corporate purposes, including investing in additional key strategic hires, product portfolio expansion and research and development. Aspira…

Hologic and Google Cloud Announce Collaboration to Advance Next Generation Digital Diagnostic Capabilities in Cervical Cancer Screening

Hologic announced today a multi-year strategic collaboration with Google Cloud that will feature the integration of Google Cloud’s machine learning (ML) technologies with Hologic’s cutting-edge Genius Digital Diagnostics System to transform screening and accelerate the eradication of cervical cancer across the globe. Genius Digital Diagnostics is the first digital cytology platform to combine artificial intelligence (AI) with advanced digital imaging to help identify pre-cancerous…